Navigation Links
Increased Demand for Visual Healthcare ADE Prevention Platform
Date:5/18/2011

RENO, Nev., May 18, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a direct response to the Obama administration 1 billion dollar patient-safety program aimed at reducing preventable medical errors.

The stand alone version, still running on an Oracle (ORCL) data base, will be installed in a matter of weeks and operational immediately as it requires minimal training for clinicians. The resulting cost savings are passed on to the hospital which can then recoup its investment in less than a year. Adverse drug events represent a serious financial concern as they cost an average of some $7,000 per case, adding up to an annual burden in the millions.

"We will be signing deals in the next 30 days which could have an impact as early as the current quarter," says Chairman Gerard Dab.  "Pressure from the White House is having a strong impact on the marketplace. Early adopters seeking to move ahead will be signing some 20 deals having a value of more than 15M in the next 12 months. Subsequently as budgets increase, growth of this product line will continue to be exponential," concludes Mr. Dab.

This watershed program follows the publishing of a study showing that one in three patients admitted to hospitals suffers a medical error or accident. Through this program, President Obama is challenging hospitals to dramatically cut mistakes and readmissions due to preventable errors or negligence by 40 percent and cutting preventable hospital readmissions by 20 percent. The first tranche of 1 billion is being funneled to the industry under the Patient Protection and Affordable Act.

"Reducing the massive incidence of drug errors in hospital can only be achieved by automation and using smart systems like ours," says Mr. Dab.  "We have waited long years to have the need for our technology recognized by Public Policy. This program demonstrates the seriousness of the Obama commitment to modernizing the healthcare industry."

Visual Healthcare platforms for Adverse Drug Event applications are used successfully by over one thousand clinicians and have been demonstrated to reduce both morbidity and cost associated with hospital errors by more than 30% and deadly errors by 50%.

ABOUT VISUAL HEALTHCARE

Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications.  They also include quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries. The company's extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (NASDAQ OTC: VMCS), a leader in the field of electronic health records.

For more information, please visit: www.visualhealthcarecorp.com.

FORWARD- LOOKING STATEMENTS

Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

Contact:
Gerard Dab, CEO
Visual Healthcare Corp.
514-582-5220


'/>"/>
SOURCE Visual Healthcare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Two New Studies in the British Medical Journal Find That Bayers Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot
2. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
3. CVS Caremark Insights 2011 Report Highlights Lowest Drug Trend in Six Years and Increased Utilization of Generics
4. Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes
5. MSA Increases Production of Air-Purifying Respirators to Help Meet Increased Demand from Japan
6. New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers
7. Study of Patients on Chronic Opioid Therapy finds Likely Non-adherent Patients Have Increased Healthcare Costs, More Hospital Days
8. Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction
9. ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China
10. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
11. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
Breaking Medicine News(10 mins):